THOMAS DEVINE: Open Payments
NPI 1942204508 · VALPARAISO, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$952 in 55 payments from 16 companies in 2025. Trend: 2023 $908 · 2024 $1,452 · 2025 $952
Food & beverage: $931Education: $20
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 16 | $245 |
| ABBVIE INC. | 10 | $182 |
| Novo Nordisk Inc | 6 | $108 |
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| Radius Health, Inc. | 3 | $50 |
| Novartis Pharmaceuticals Corporation | 2 | $47 |
| Lilly USA, LLC | 3 | $45 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| Exact Sciences Corporation | 2 | $36 |
Products named: NURTEC ODT, PAXLOVID, QULIPTA, LINZESS, Wegovy, ELIQUIS, MOUNJARO, Kerendia.
Industry payments across IN — which companies pay providers there.
